Measles Rapid IgM Test Kit Distribution in Latin America

Basic Details

Item	Value
Title	Measles Rapid IgM Test Kit Distribution in Latin America
Type	Product
Difficulty	65
Ideal Capital	30000
ROI	35%
ETA on ROI	12
Target Audience	Private clinics, chain pharmacies, diagnostic labs, public health programs
Target Countries	Mexico, Brazil, Colombia, Peru, Argentina
Target Demographics	Healthcare procurement officers, clinic owners, health ministry officials, 35-60, decision-makers
Description	Import and distribute rapid chromatographic immunoassay test kits for measles IgM/IgG detection (similar to COVID rapid tests). Partner with established manufacturers (e.g., CTK Biotech, Abbott) for white-label or distribution rights. Obtain necessary medical device registrations (COFEPRIS in Mexico, ANVISA in Brazil). Sell boxes of 20 tests for $100 wholesale to clinics and pharmacies. Package with training materials and outbreak response protocols.
Monetization	Direct product sales with 35% gross margin; bulk contracts with health ministries.
Pros	High demand during outbreaks with potential for recurrent orders Existing distribution channels for rapid tests post-COVID can be leveraged Relatively simple product with no cold chain requirements
Cons	Stringent medical device regulatory approvals (time and cost) Demand fluctuates with outbreak cycles; inventory risk Competition from established diagnostic companies and local manufacturers